As for NAION, people with Type 2 diabetes are already at an increased risk of developing the disease, as are those who smoke or have hypertension or high cholesterol.
Thus, future studies should consider validating the selective radioprotective potential of ebselen through rigorous pre-clinical and clinical studies
doi:10.1073/pnas.89.18.8641
By addressing considerations related to patient selection, monitoring, education, and collaboration, healthcare providers can optimize the safe and effective use of Semaglutide in lupus patients, contributing to improved glycemic control, weight management, and overall health outcomes
How is this different from prescription weight-loss medication